Proteome Sciences (LON:PRM) Stock Price Down 9.8% – Here’s Why

Proteome Sciences plc (LON:PRM) shares fell 9.8% on Wednesday . The company traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). 41,420 shares were traded during trading, a decline of 55% from the average session volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).

Proteome Sciences Stock Down 9.8 %

The company has a 50 day moving average of GBX 2.90 and a 200 day moving average of GBX 3.12. The firm has a market cap of £9.37 million, a price-to-earnings ratio of -317.50 and a beta of 0.07.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.